What Happened
A psychiatrist and addiction-medicine physician with a private practice in Clifton Park, New York arranged for a patient to kick back part of each methylphenidate (generic Ritalin) prescription for the physician's own personal use.
When that arrangement alone wasn't enough, the physician fraudulently obtained the names and birthdates of the patient's children and used that stolen personal information to issue additional methylphenidate prescriptions in the children's names. The patient picked up those prescriptions and split the medication with the physician. Separately, in a related civil matter, the physician admitted to improperly prescribing intranasal ketamine to a patient with no legitimate medical need and to serious recordkeeping failures — including not documenting dosage amounts, patient names, or who administered each injection.
He pleaded guilty on September 17, 2020, to distributing controlled substances outside the course of professional practice and to misusing personal identifying information, surrendered his New York medical license, and separately settled the civil ketamine claims for $43,225.24.
What Went Wrong
- A prescriber diverted through a compliant patient rather than direct theft. The kickback arrangement let the physician obtain drugs without ever touching pharmacy inventory himself, making it harder to detect through typical facility controls.
- Patients' family members' identities were used without any independent verification. Pharmacies dispensed controlled substances to minors' identities without confirming the prescriptions matched an actual patient relationship with the prescriber.
- Ketamine treatment records were not maintained as required. The practice lacked basic recordkeeping — dosage, patient identity, and administering staff — that would have made improper use easier to catch.
How It Could Have Been Prevented
- Require pharmacies and PDMPs to flag controlled-substance prescriptions issued to minors or dependents of an existing adult patient of the same prescriber for extra review.
- Mandate complete treatment documentation — dosage, patient identity, administering clinician — for every controlled-substance administration, including office-based treatments like ketamine.
- Audit prescribing patterns for repeat prescriptions to closely related identities (e.g., patient and patient's children) at the same practice.
- Train pharmacy staff to question prescriptions for controlled substances issued to pediatric patients without a documented pediatric visit history.
Related Guidance
- 15 Red Flags of Drug Diversion — Indicators including prescribing patterns and identity misuse.
- Regulatory Guide — Recordkeeping requirements for controlled-substance treatments.
- Diversion Case Registry — Related prescriber self-diversion cases.
- Diversion Prevention Checklist — Controls applicable to outpatient prescribing practices.